I encourage all to read the article All_Aboard just posted, or, at minimum, up to line 80. It's an open access article so you can download the whole thing. The first few pages highlight just the enormous, enormous potential of MANF across so many high value therapeutic areas. AMBS has the IP covering all of them. That's one thing AMBS has actually done well - protecting their IP.

The article also makes reference to the 'Science' publication from last year.

It is absolutely crazy that this stock traded all the way down to 1 cent, IMO.